Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline

por Sandison, Heather, Callan, Nini G.L., Rao, Rammohan V., Phipps, John, Bradley, Ryan
Publicado 2023

Xanthohumol microbiome and signature in adults with Crohn’s disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial

por Langley, Blake O., Ryan, Jennifer Joan, Phipps, John, Buttolph, Lita, Bray, Brenna, Aslan, Joseph E., Metz, Thomas O., Stevens, Jan F., Bradley, Ryan
Publicado 2022

Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial

por Bradley, Ryan, Langley, Blake O., Ryan, Jennifer J., Phipps, John, Hanes, Douglas A., Stack, Emily, Jansson, Janet K., Metz, Thomas O., Stevens, Jan Frederik
Publicado 2020

Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial

por Bradley, Ryan, Langley, Blake O., Ryan, Jennifer J., Phipps, John, Hanes, Douglas A., Stack, Emily, Jansson, Janet K., Metz, Thomas O., Stevens, Jan Frederik
Publicado 2020